February 27, 2017 by Mark Baumgartner and Chain Drug Review
Martin Sorrell, Stefano Pessina, Team WBA, Walgreens, Walgreens Boots Alliance, WPP
2017, Issue 02-27-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance has selected a dedicated agency team at WPP, the world’s largest marketing and advertising agency, to handle its global marketing and communications account. The drug store operator will work with Team WBA, a bespoke team of WPP agencies assigned to handle the retailer’s traditional and digital advertising, media buying
February 15, 2017 by Chain Drug Review
Brian Cornell, President Donald Trump, retail industry, Retail Industry Leaders Association, RILA, Stefano Pessina, Target Corp., video, Walgreens Boots Alliance
Leading Headlines, Videos
WASHINGTON — Promoting his economic platform with business leaders, President Donald Trump today met with top retail executives at the White House. Focusing on Trump’s plank of job creation, simplification of the tax code and reduced regulatory red tape, the Wednesday morning meeting was a scheduled event with the Retail Industry Leaders Association (RILA). The
February 6, 2017 by Geoff Walden and Chain Drug Review
CVS Health, David Denton, Edith Ramirez, Federal Trade Commission, Fred's, Maureen Ohlhausen, Rite Aid, Stefano Pessina, Terrell McSweeny, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 02-06-2017, Issues, News
WASHINGTON — The acquisition of Rite Aid Corp. by Walgreens Boots Alliance (WBA) Inc. remained unconsummated after WBA’s plan to divest 865 stores failed to erase antitrust regulators’ competitive concerns. When the Friday, January 27, deadline for completing the Walgreens-Rite Aid merger deal arrived, the Federal Trade Commission still hadn’t cleared the transaction, despite the
February 1, 2017 by Chain Drug Review
Alliance Healthcare, Boots, Martin Sorrell, Stefano Pessina, Team WBA, Walgreens, Walgreens Boots Alliance, WPP
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) Inc. has teamed up with global advertising and public relations giant WPP plc in a wide-ranging marketing and communications partnership for its businesses and brands. WBA said late Tuesday that WPP will operate and develop multiple marketing and communications channels for its retail and wholesale divisions and its
January 26, 2017 by Chain Drug Review
Fred's, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA's annual shareholders meeting
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — Walgreens Boots Alliance (WBA) is still negotiating with the Federal Trade Commission to gain antitrust clearance for its $17 billion deal to acquire Rite Aid Corp., WBA executive vice chairman and chief executive officer Stefano Pessina said at the company’s annual shareholders meeting. “The FTC is doing its job. The process is
January 16, 2017 by David Pinto and Chain Drug Review
Albertsons, America’s drug chains, Bob Miller, CVS Health, David Pinto, Doug McMillon, George Riedl, Helena Foulkes, John Standley, Larry Merlo, Ornella Barra, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walmart
2017, Issue 01-16-2017, Issues, Opinion
Going into the new year, several key personnel questions await answers, foremost among them the age-old problem of determining who, in 2017, will emerge as the most influential senior staffers at America’s drug chains. The determination is made more difficult by the fact that, as of this writing, Walgreens’ acquisition of Rite Aid remains unresolved.
January 5, 2017 by Chain Drug Review
Fred's, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) edged past Wall Street’s adjusted earnings per share forecast in its fiscal 2017 first quarter despite declined sales and net income. WBA also reported Thursday that it’s still working to finalize its $17 billion deal to acquire Rite Aid Corp. and continues to expect to complete the transaction
January 2, 2017 by Greg Jacobson and Chain Drug Review
Alex Gourlay, Brian Tanquilut, Fred's, Jefferies LLC, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 01-02-2017, Issues, News
NEW YORK — Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. have agreed to sell 865 Rite Aid stores and related assets to Fred’s Inc. for $950 million in cash. The deal is subject to approval by the Federal Trade Commission as well as approval and completion of the pending WBA acquisition of Rite
January 2, 2017 by Jeffrey Woldt and Chain Drug Review
Fred's, Jeffrey Woldt, John Standley, Ken Martindale, Mike Bloom, Rite Aid, sale of the Rite Aid stores to Fred’s, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 01-02-2017, Issues, Opinion
The agreement struck last month for the sale of 865 Rite Aid Corp. drug stores to Fred’s Inc. is a momentous development for those companies, as well as Walgreens Boots Alliance, which after 14 months is still working to finalize the acquisition of Rite Aid. The $950 million all-cash deal will bring Fred’s stores and
November 9, 2016 by CDR Blog and Chain Drug Review
Deutsche Bank Securities, Federal Trade Commission, George Hill, private equity, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, WBA-Rite Aid merger
CDR Blog, Leading Headlines
Walgreens Boots Alliance and Rite Aid recently extended the agreement end date for their merger transaction until late January, with the expectation that the deal will get the Federal Trade Commission’s OK in early 2017. As WBA’s store divestiture talks with the FTC roll on, Deutsche Bank Securities analyst George Hill shed some light on
November 7, 2016 by Geoff Walden and Chain Drug Review
CVS Health, Deutsche Bank Securities, Federal Trade Commission, George Hill, Kroger, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walmart, WBA-Rite Aid merger
2016, Issue 11-07-2016, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. have extended the time frame for completing their planned $17.2 billion merger. The companies have pushed back the end date for the deal by three months to January 27, and they expect the transaction to close early next year. Both companies had the
November 2, 2016 by Chain Drug Review
Alliance Boots merger, Barry Rosenstein, Dominic Murphy, JANA Partners, KKR, Kohlberg Kravis Roberts, Stefano Pessina, Walgreens Boots Alliance, WBA board of directors
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Affiliates of private equity firm Kohlberg Kravis Roberts & Co. (KKR) plan to sell their remaining interest in Walgreens Boots Alliance (WBA) through a secondary stock offering. WBA said Wednesday that the KKR affiliates aim to sell 20.46 million shares of WBA common stock in an underwritten secondary offering. And in a
October 21, 2016 by CDR Blog and Chain Drug Review
Brian Tanquilut, George Fairweather, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Not much else about the progress of the Walgreens-Rite Aid merger came out in yesterday’s fourth-quarter earnings conference call by Walgreens Boots Alliance. A swirl of media reports in recent months have gone back and forth about the number of store divestitures and whether the Federal Trade Commission will end up signing off on the
October 20, 2016 by Chain Drug Review
AmerisourceBergen, Express Scripts, Prime Therapeutics, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, Leading Headlines, Retail News
DEERFIELD, Ill. — As talks roll on to gain regulatory clearance for its acquisition of Rite Aid Corp., Walgreens Boots Alliance (WBA) posted adjusted earnings for its fiscal 2016 fourth quarter and full year that beat Wall Street’s estimates. WBA said Thursday that GAAP net earnings attributable to Walgreens Boots Alliance totaled $1.03 billion, or